Back to Results
First PageMeta Content
Ribbon symbolism / Gamma probe / Sentinel lymph node / Breast cancer / Invasiveness of surgical procedures / Medical imaging / Medicine / Medical physics / Nuclear medicine


20110927PressFDAUSA_SurgicEye
Add to Reading List

Document Date: 2011-09-29 05:47:11

Open Document

File Size: 24,59 KB

Share Result on Facebook

City

New York / Paris / Washington / D.C. / Munich / /

Company

Dilon Diagnostics / Sentinel / Dilon Technologies Inc. / SurgicEye / /

Country

Germany / France / United States / /

/

Event

FDA Phase / Business Partnership / /

Facility

The George Washington University Medical Center / Women's Hospital / Cornell University Medical Center / Hotel Dieu / /

IndustryTerm

intraoperative imaging technology / intraoperative soft tissue imaging / molecular breast imaging procedure / molecular breast imaging / intraoperative gamma probe 3D visualization device / cornerstone product / breast cancer applications / navigation solutions / digital imaging solutions / technology fits / imaging / medical imaging products / clinically advanced solutions / declipseSPECT technology / tech and high-quality solutions / /

MedicalCondition

primary breast tumors / melanoma / breast cancer / tumor / cancer / Tumors / metastases / /

MedicalTreatment

invasive procedures / surgery / surgeries / /

Organization

The George Washington University / Cornell University Medical Center / Women's Hospital / George Washington University Medical Center / U.S. Food and Drug Administration / FDA / /

Person

Marion Kiechle / Robert Moussa / Stefan Paepke / Joerg Traub / Andreas Schnelzer / Claudia Ramirez-Wiesner / /

/

Position

CEO / leader / Director / /

Product

Dilon 6800 / CSS300 / /

ProvinceOrState

New York / /

Technology

declipseSPECT technology / so-called freehand SPECT technology / 3-D / digital imaging / intraoperative imaging technology / medical imaging / /

URL

www.dilon.com / www.surgiceye.com / /

SocialTag